News

The Hong Kong Polytechnic University (PolyU) will join forces with Axis Therapeutics, a newly established joint venture by two global biopharmaceutical companies - Athenex, Inc. and…
Read More...

About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The invariably fatal disease kills the nerve cells that…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved SYMTUZA, the first and only complete,…
Read More...

Sanofi and REVOLUTION Medicines announced an exclusive worldwide partnership to develop and commercialize targeted therapies, based on the biology of the cellular enzyme SHP2, for…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) as…
Read More...

Asceneuron SA announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to ASN120290 for the treatment of progressive supranuclear palsy (PSP), a…
Read More...

Innovest Global Inc. launched its anticipated Biotechnology & Health Services Division with the acquisition of a twenty percent interest in StemVax Therapeutics, a Translational…
Read More...

Taconic Biosciences and Cyagen Biosciences announced a strategic partnership. Under the agreement terms, the two companies will combine resources to provide the global scientific…
Read More...

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc. provided an overview of their TAK-935/OV935 broad clinical development program. The companies plan to initiate three…
Read More...

Sterigenics announced that it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to…
Read More...

Advanced Proteome Therapeutics Corporation announced the collaboration of APC with Noria Pharmaceuticals Inc. in the rapidly growing field of antibody radioisotope conjugates. APC…
Read More...

AbbVie announced patent license agreements with Mylan over its proposed biosimilar adalimumab product. Under the terms of the agreements, AbbVie will grant Mylan a non-exclusive license…
Read More...

Sinovant Sciences and Renexxion announced the initiation of a collaboration to pursue the development of naronapride, an investigational gastrointestinal prokinetic, in Greater China.…
Read More...

leon-nanodrugs GmbH announce that its proprietary MicroJet Reactor (MJR) nano-technology has been selected by Takeda Pharmaceutical Company Ltd. (Takeda) for a feasibility assessment…
Read More...

Edge Pharmacy Services, LLC announced that it has acquired Apolab ULC of Mississauga, Ontario. Edge is a rapidly growing US based 503B Outsourcing facility with business elements…
Read More...

Nohla Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Nohla’s lead product candidate, dilanubicel (NLA101), Orphan Drug Designation for reduction of…
Read More...

Cryoport announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport's full suite of temperature-controlled solutions into its global network. This integrated…
Read More...

GSK announced that Dermavant Sciences, a subsidiary of Roivant Sciences, has agreed to purchase the rights to tapinarof, an investigational therapeutic aryl hydrocarbon receptor…
Read More...

The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Organization declared smallpox,…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) seeking approval…
Read More...